More tools:Markets·Screener·Research·Chat

Moderna, Inc. Common Stock (MRNA) Financial Statements

Moderna, Inc. Common Stock
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG003PHHZV8
XNAS · usd
60.79▲ 0.22 (0.36%)
As of 2026-08-12
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)$2.2B
Net Income (TTM)-$3.2B
EBITDA
Diluted EPS (TTM)
EBITDA Margin-138.7%
Net Debt
Trading Information
Previous Close60.57
Day's Range58.60 – 61.40
52-Week Range22.28 – 85.60
Volume6.5M
Avg Volume6.3M
Share Statistics
Shares Outstanding396.8M
Employees4,700
ExchangeXNAS
Listed2018-12-07
Loading Income Statement…
Key questions about Moderna, Inc. Common Stock (MRNA)
What is Moderna, Inc. Common Stock's Market Cap?
Moderna, Inc. Common Stock's Market Cap is $24.1B, based on as-reported figures from SEC (XBRL) filings.
What is Moderna, Inc. Common Stock's Enterprise Value?
Moderna, Inc. Common Stock's Enterprise Value is $23.1B, based on as-reported figures from SEC (XBRL) filings.
What is Moderna, Inc. Common Stock's Price / Sales?
Moderna, Inc. Common Stock's Price / Sales is 10.8×, based on as-reported figures from SEC (XBRL) filings.
What is Moderna, Inc. Common Stock's EV / Revenue?
Moderna, Inc. Common Stock's EV / Revenue is 10.4×, based on as-reported figures from SEC (XBRL) filings.
What is Moderna, Inc. Common Stock's EV / EBITDA?
Moderna, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Moderna, Inc. Common Stock's Revenue (TTM)?
Moderna, Inc. Common Stock's Revenue (TTM) is $2.2B, based on as-reported figures from SEC (XBRL) filings.
What is Moderna, Inc. Common Stock's Net Income (TTM)?
Moderna, Inc. Common Stock's Net Income (TTM) is -$3.2B, based on as-reported figures from SEC (XBRL) filings.
What is Moderna, Inc. Common Stock's EBITDA?
Moderna, Inc. Common Stock's EBITDA is -$3.1B, based on as-reported figures from SEC (XBRL) filings.
What is Moderna, Inc. Common Stock's Diluted EPS (TTM)?
Moderna, Inc. Common Stock's Diluted EPS (TTM) is -7.94, based on as-reported figures from SEC (XBRL) filings.
What is Moderna, Inc. Common Stock's EBITDA Margin?
Moderna, Inc. Common Stock's EBITDA Margin is -138.7%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Total revenue
YoY growth+2.1%+260.2%-29.8%-45.4%
Operating expenses:
Cost of sales
Research and development
Selling, general and administrative
Total operating expenses
% of revenue662.1%456.8%226.4%125.6%
Loss from operations
% of revenue-562.1%-356.8%-126.4%-25.6%
Interest income
Other (expense) income, net
Loss before income taxes
Provision for income taxes
Net loss
% of revenue-539.3%-345.2%-121.8%-19.7%
Basic (in usd per share)—
Diluted (in usd per share)—
Net loss per share attributable to common stockholders, basic and diluted (usd per share)————